MindWalk Holdings (HYFT) Cash & Equivalents (QoQ) (2021 - 2026)
MindWalk Holdings (HYFT) Cash & Equivalents (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -17.45% |
| Jan 31, 2026 | -14.79% |
| Oct 31, 2025 | 233.91% |
| Jul 31, 2025 | -53.04% |
| Apr 30, 2025 | -17.16% |
| Jan 31, 2025 | 245.49% |
| Oct 31, 2024 | -9.23% |
| Jul 31, 2024 | 11.73% |
| Apr 30, 2024 | -43.80% |
| Jan 31, 2024 | 3.34% |
| Oct 31, 2023 | -11.81% |
| Jul 31, 2023 | -17.44% |
| Apr 30, 2023 | -26.90% |
| Jan 31, 2023 | -25.40% |
| Oct 31, 2022 | -24.22% |
| Jul 31, 2022 | -36.93% |
| Apr 30, 2022 | -8.97% |
| Jan 31, 2022 | -14.59% |
| Oct 31, 2021 | -7.90% |
| Jul 31, 2021 | -0.31% |